期刊文献+

微型癥瘕理论在治疗糖尿病黄斑水肿围手术期中的应用 被引量:3

Application of micro-Zhengjia theory in the treatment of diabetic macular edema during perioperative period
原文传递
导出
摘要 糖尿病视网膜病变(DR)是糖尿病最严重的并发症之一,随着对疾病研究的不断深入,玻璃体腔抗血管内皮生长因子(VEGF)药物注射治疗成为糖尿病性黄斑水肿(DME)主流治疗方案。文章总结了许家骏教授运用中医微型癥瘕理论在DME患者围手术期进行治疗的思路和方法,针对患者不同的眼底表现及全身症状辨证,在益气养阴的基础上治以祛痰、解郁、清热、化瘀,祛邪扶正,并联合玻璃体腔抗VEGF药物注射,改善患者眼部及全身症状,临床疗效较佳,可进一步推广。 Diabetic retinopathy(DR) is one of the most serious complications of diabetes. With the deepening of research on the disease, the anti-VEGF drug injection has become the mainstream treatment for diabetic macular edema(DME).For patients with DME, professor XU Jia-jun uses the TCM theory of micro-Zhengjia to treat them during the perioperative period. According to different patient’s manifestations of fundus and systemic symptom, on the basis of supplementing qi and nourishing yin, he dialectically treats with expectorant, resolving depression, clearing heat, and removing blood stasis, as well as upholding healthy qi and exorcising pathogenic qi, combining the anti-VEGF drug injection, improving patient’s ocular and systemic symptom. This method has better curative effect and can be further promoted.
作者 叶梓萱 徐艺宸 贾楠 杨冬妹 许家骏 张南 YE Zi-xuan;XU Yi-chen;JIA Nan;YANG Dong-mei;XU Jia-jun;ZHANG Nan(Dongzhimen Hospital,Beijing University of Chinese Medicine,Beijing 100700,China)
出处 《中华中医药杂志》 CAS CSCD 北大核心 2021年第11期6511-6514,共4页 China Journal of Traditional Chinese Medicine and Pharmacy
基金 北京中医药大学东直门医院横向课题(No.HX-DZM-202125)。
关键词 糖尿病视网膜病变 微型癥瘕 玻璃体腔注药术 抗血管内皮生长因子 Diabetic retinopathy Micro-Zhengjia Vitreous cavity injection Anti-VEGF
  • 相关文献

参考文献4

二级参考文献42

共引文献1752

同被引文献54

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部